StockData
Ionis Pharmaceuticals Inc logo

Ionis Pharmaceuticals Inc (IONS) income statement

IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$27.39+0.43 (+1.59%)

Close on Nov 18, 2026Market cap $4.55BP/E –Yield –

Ionis Pharmaceuticals Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
98.2%
Operating margin
-68.0%
Net margin
-64.7%
Return on equity, FY2025
-70.8%

Financial strength

Current ratio
7.89
Debt to equity
–
Debt to assets
–
Cash to current liabilities
110.9%

Valuation

P/E ratio
–
Price to sales
5.21
Price to book
10.35
Dividend yield
–

See a number that looks wrong?